Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Abstract Text:

M Mayerhofer,K J Aichberger,S Florian,P Valent,

Traditionally, mast cells (MCs) have been considered to play an important role in allergic disorders and helminth infections. More recently, MCs have been implicated in a variety of different infectious diseases including life-threatening disorders caused by viruses and bacteria. Apart from recognition through specific IgE, MCs are considered to recognize such bacteria and viruses via specific cell surface binding sites. In addition, MCs interact with diverse components and cells of the immune system and thereby may facilitate the targeting and the elimination of invading microbes in the tissues. The current article provides an overview on MC antigens contributing to microbe recognition and targeting as an important element of natural host-defense.

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Publishing Authors By Initials

M Mayerhofer,KJ Aichberger,S Florian,P Valent,

For similar cells: connective tissue cells: mast cells research abstracts see: cells: connective tissue cells: mast cells research

PUBMED ID PMID:

MEDLINE DATE: 2007 Jul-Sep

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Journal Published:

PUBLICATION TYPE: Review

Journal: International journal of immunopathology and pharm

VOLUME: 20

Page Numbers: 421-34

Journal Abbreviation:

ISSN: 0394-6320

DAY: 29

MONTH: 11

YEAR: 2007

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Information

Number of References: 78

LANGUAGE: eng

NlmUniqueID: 8911335

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Keywords Mesh Terms:

KEYWORDS: Mast Cells

MESH TERMS: immunology

Chemical & Substance for Abstract: Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Information

Substance Name: Immunoglobulin E

Registry Number: 37341-29-0

Grant and Affiliation Information for Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.

AFFILIATION: Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Immunopathol Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense Related Publications

• A randomized double-blind study to investigate the clinical efficacy of adding a non-migrating antimicrobial to a special silk fabric in the treatment of atopic dermatitis.
• Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens.
• Anaemia of the elderly (AOE): does it exist and does it matter in clinical practice?
• Biology and clinical features of myeloid neoplasms with inv(3) (q21q26) or t(3;3) (q21q26).
• Chronic myelogenous leukemia and myeloproliferative disease.
• Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).
• Cytotoxicity of copper(II) complexes of N-salicylidene-L-glutamate: modulation by ascorbic acid.
• Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.
• Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
• Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface.
• Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
• Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy.
• Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
• Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
• Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: A hypothesis supported by unique case reports.
• Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
• Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
• Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.
• Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
• Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
• Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.
• Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.
• Revealing the pathogenesis of the 5q- syndrome.
• Roles for rice membrane dynamics and plasmodesmata during biotrophic invasion by the blast fungus.
• Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.
• Systemic mastocytosis.
• Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.
• The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.
• Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens.
• [To study fatal occupational injuries in Italy: is it possible?]